Role of medicinal plants in the treatment of eumycetoma: A review
暂无分享,去创建一个
M. Jayanthi | Ramu Ramith | M. P. Shashank | Chandra Jagadeep | S. Prithvi | J. M K | Patil Shashank M. | Shirahatti Prithvi S.
[1] M. A. Mohamed,et al. Madurella mycetomatis causing eumycetoma medical treatment: The challenges and prospects , 2020, PLoS Neglected Tropical Diseases.
[2] P. Fournier,et al. Actinomycetoma Caused by Actinomadura mexicana, A Neglected Entity in the Caribbean , 2020, Emerging infectious diseases.
[3] T. Boekhout,et al. Madurella real-time PCR, a novel approach for eumycetoma diagnosis , 2020, PLoS neglected tropical diseases.
[4] M. Shokri,et al. Recurrent eumycetoma caused by novel species Madurella pseudomycetomatis: A case report , 2019, Medical mycology case reports.
[5] Hassan,et al. Boswellia and Commiphora Species as a Resource Base for Rural Livelihood Security in the Horn of Africa: A Systematic Review , 2019, Forests.
[6] D. Soleša,et al. Tea tree (Melaleuca alternifolia) and its essential oil: antimicrobial, antioxidant and acaricidal effects in poultry production , 2019, World's Poultry Science Journal.
[7] B. Salehi,et al. Piper Species: A Comprehensive Review on Their Phytochemistry, Biological Activities and Applications , 2019, Molecules.
[8] A. Jha,et al. Mycetoma: reviewing a neglected disease , 2018, Clinical and experimental dermatology.
[9] P. Balatti,et al. Identification of an intermediate for 1,8-dihydroxynaphthalene-melanin synthesis in a race-2 isolate of Fulvia fulva (syn. Cladosporium fulvum) , 2018, Heliyon.
[10] R. Hay,et al. Mycetoma: The Spectrum of Clinical Presentation , 2018, Tropical medicine and infectious disease.
[11] S. P. Dumre,et al. Mycetoma: a clinical dilemma in resource limited settings , 2018, Annals of Clinical Microbiology and Antimicrobials.
[12] A. Fahal,et al. A holistic approach to the mycetoma management , 2018, PLoS neglected tropical diseases.
[13] E. Reis-Filho,et al. Mycetomas: an epidemiological, etiological, clinical, laboratory and therapeutic review* , 2018, Anais brasileiros de dermatologia.
[14] B. Salehi,et al. Plants of the Genus Zingiber as a Source of Bioactive Phytochemicals: From Tradition to Pharmacy , 2017, Molecules.
[15] V. Garg,et al. Mycetoma: An Update , 2017, Indian journal of dermatology.
[16] A. Fahal,et al. Combining two antifungal agents does not enhance survival of Galleria mellonella larvae infected with Madurella mycetomatis , 2017, Tropical medicine & international health : TM & IH.
[17] V. Kuete. Other Health Benefits of African Medicinal Spices and Vegetables , 2017 .
[18] A. Osman. Functional Characteristics of Gum from Acacia Nubica , 2016 .
[19] A. Fahal,et al. Mycetoma Pulmonary Secondaries from a Gluteal Eumycetoma: An Unusual Presentation , 2016, PLoS neglected tropical diseases.
[20] Y. Keum,et al. Phytochemicals of Moringa oleifera: a review of their nutritional, therapeutic and industrial significance , 2016, 3 Biotech.
[21] A. Nasr,et al. Th-1, Th-2 Cytokines Profile among Madurella mycetomatis Eumycetoma Patients , 2016, PLoS neglected tropical diseases.
[22] M. Goodfellow,et al. Mycetoma: a unique neglected tropical disease. , 2016, The Lancet. Infectious diseases.
[23] A. Fahal,et al. Eumycetoma and actinomycetoma – an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[24] H. Verbrugh,et al. A Polymorphism in the Chitotriosidase Gene Associated with Risk of Mycetoma Due to Madurella mycetomatis Mycetoma–A Retrospective Study , 2015, PLoS neglected tropical diseases.
[25] N. Hjira,et al. Madura foot: Report of a eumycetoma Moroccan case , 2015 .
[26] Wendy Kloezen,et al. The In Vitro Antifungal Activity of Sudanese Medicinal Plants against Madurella mycetomatis, the Eumycetoma Major Causative Agent , 2015, PLoS neglected tropical diseases.
[27] S. Ehara,et al. The “dot-in-circle” sign in musculoskeletal mycetoma on magnetic resonance imaging and ultrasonography , 2014, SpringerPlus.
[28] A. Fahal,et al. Mycetoma Medical Therapy , 2014, PLoS neglected tropical diseases.
[29] A. Fahal,et al. A New Model for Management of Mycetoma in the Sudan , 2014, PLoS neglected tropical diseases.
[30] A. Bonifaz,et al. Mycetoma: Experience of 482 Cases in a Single Center in Mexico , 2014, PLoS neglected tropical diseases.
[31] M. Goodfellow,et al. Merits and Pitfalls of Currently Used Diagnostic Tools in Mycetoma , 2014, PLoS neglected tropical diseases.
[32] G. S. de Hoog,et al. Madurella mycetomatis Is Highly Susceptible to Ravuconazole , 2014, PLoS neglected tropical diseases.
[33] M. Goodfellow,et al. The Mycetoma Knowledge Gap: Identification of Research Priorities , 2014, PLoS neglected tropical diseases.
[34] W. V. D. van de Sande. Global Burden of Human Mycetoma: A Systematic Review and Meta-analysis , 2013, PLoS neglected tropical diseases.
[35] L. Quintella,et al. Eumycetoma by Madurella mycetomatis with 30 years of evolution: therapeutic challenge* , 2013, Anais brasileiros de dermatologia.
[36] A. Fahal,et al. Mycetoma Herbal Treatment: The Mycetoma Research Centre, Sudan Experience , 2013, PLoS neglected tropical diseases.
[37] Aftab Ahmad,et al. A review on therapeutic potential of Nigella sativa: A miracle herb. , 2013, Asian Pacific journal of tropical biomedicine.
[38] B. Stielow,et al. Phylogenetic Findings Suggest Possible New Habitat and Routes of Infection of Human Eumyctoma , 2013, PLoS neglected tropical diseases.
[39] A. Fahal,et al. A Histopathological Exploration of the Madurella mycetomatis Grain , 2013, PloS one.
[40] J. Meis,et al. In Vitro Antifungal Activity of Isavuconazole against Madurella mycetomatis , 2012, Antimicrobial Agents and Chemotherapy.
[41] M. Nicholson,et al. A nodulo-cystic eumycetoma caused by Pyrenochaeta romeroi in a renal transplant recipient: A case report , 2011, Journal of medical case reports.
[42] M. Z. Siddiqui. Boswellia Serrata, A Potential Antiinflammatory Agent: An Overview , 2011, Indian journal of pharmaceutical sciences.
[43] E. Zijlstra,et al. The safety and efficacy of itraconazole for the treatment of patients with eumycetoma due to Madurella mycetomatis. , 2011, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[44] M. VAN DER BANK,et al. The evolutionary history and biogeography of Mimosoideae (Leguminosae): an emphasis on African acacias. , 2010, Molecular phylogenetics and evolution.
[45] N. Afroz,et al. Eumycetoma versus actinomycetoma: Diagnosis on cytology , 2010, Journal of cytology.
[46] A. van Belkum,et al. Madurella mycetomatis Is Not Susceptible to the Echinocandin Class of Antifungal Agents , 2010, Antimicrobial Agents and Chemotherapy.
[47] F. Hao,et al. Phenotypic and Molecular Characterization of Madurella pseudomycetomatis sp. nov., a Novel Opportunistic Fungus Possibly Causing Black-Grain Mycetoma , 2009, Journal of Clinical Microbiology.
[48] A. Fahal,et al. Mycetoma revisited. Incidence of various radiographic signs. , 2009, Saudi medical journal.
[49] M. Asad,et al. Anti-stress activity of hydro-alcoholic extract of Eugenia caryophyllus buds (clove) , 2009, Indian journal of pharmacology.
[50] A. De Sarro,et al. New and Investigational Triazole Agents for the Treatment of Invasive Fungal Infections , 2008, Journal of chemotherapy.
[51] O. Kniemeyer,et al. Production of Pyomelanin, a Second Type of Melanin, via the Tyrosine Degradation Pathway in Aspergillus fumigatus , 2008, Applied and Environmental Microbiology.
[52] A. Bonifaz,et al. Utility of helical computed tomography to evaluate the invasion of actinomycetoma; a report of 21 cases , 2008, The British journal of dermatology.
[53] M. Ameen,et al. Emerging therapeutic regimes for the management of mycetomas. , 2008, Expert opinion on pharmacotherapy.
[54] D. Denning,et al. New and emerging treatments for fungal infections. , 2008, The Journal of antimicrobial chemotherapy.
[55] A. van Belkum,et al. Melanin biosynthesis in Madurella mycetomatis and its effect on susceptibility to itraconazole and ketoconazole. , 2007, Microbes and infection.
[56] A. van Belkum,et al. In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin. , 2007, The Journal of antimicrobial chemotherapy.
[57] T. Riley,et al. Melaleuca alternifolia (Tea Tree) Oil: a Review of Antimicrobial and Other Medicinal Properties , 2006, Clinical Microbiology Reviews.
[58] A. Fahal. Mycetoma: a thorn in the flesh. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[59] A. van Belkum,et al. Madurella mycetomatis Strains from Mycetoma Lesions in Sudanese Patients Are Clonal , 2003, Journal of Clinical Microbiology.
[60] M. Brandt,et al. Epidemiology, Clinical Manifestations, and Therapy of Infections Caused by Dematiaceous Fungi , 2003, Journal of chemotherapy.
[61] A. van Belkum,et al. Environmental Occurrence of Madurella mycetomatis, the Major Agent of Human Eumycetoma in Sudan , 2002, Journal of Clinical Microbiology.
[62] A. Fahal. The management of mycetoma. , 2010 .